Translational research in microbiome (intramic): an area of common and growing interest at imtib, hospital italiano and instituto universitario
Article Sidebar
Main Article Content
Abstract
It is estimated that approximately 100 trillion microorganisms (including bacteria, viruses, and fungi) reside in the adult human intestine, and that the total genetic material of the microbiome is 100 times greater than that of the human genome. This community, known as the microbiome, is acquired at birth through the commensal flora of the mother’s skin, vagina, and feces and remains relatively stable after two years, playing a critical role in both the state of health and in disease. The development of new technologies, such as next-generation sequencers (NGS), currently allow for a much more precise study of it than in past decades when it was limited to cultivation. Although this has led to exponential growth in publications, data on Latin American populations is almost non-existent. Translational research in microbiome (InTraMic) is one of the lines developed at the Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB). This started in 2018 with the Colorectal Cancer Line (CRC) in a collaboration with the Colorectal Cancer Research Group of the Leeds Institute of Medical Research in the project “Large bowel microbiome disease network: Creation of a proof of principle exemplar in colorectal cancer across three continents”. At the end of 2019, the objective of verifying the feasibility of collecting, sending and analyzing MBF samples on 5 continents, including samples from Argentina, Chile, India and Vietnam, was met. After having participated in training in England, the objective of the pilot stage has been met, achieving the collection, delivery and metagenomic analysis from the sequencing of the V4 region of the 16S rRNA. In 2019, the non-alcoholic fatty liver disease line joined InTraMic, initiating a pilot characterization in the framework of a collaboration with the Novartis laboratory. The results of that study, as well as that of colorectal cancer, are being published. In 2020, with the incorporation of the allogeneic hematopoietic stem cell transplantation line, a project was presented for a grant from the CONICET that has passed the first stage of evaluation. This article provides an update on the taxonomic characterization of the microbiome and describes the lines of ongoing research.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human–microbe mutualism and disease. Nature. 2007; 449:811-8. DOI: https://doi.org/10.1038/nature06245
Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011; 473:174-80. DOI: https://doi.org/10.1038/nature09944
Mobeen F, Sharma V, Prakash T. Enterotype Variations of the Healthy Human Gut Microbiome in Different Geographical Regions. Bioinformation. 2018; 14:560-73. DOI: https://doi.org/10.6026/97320630014560
Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc. 2012; 87:701-30. DOI: https://doi.org/10.1111/j.1469-185X.2012.00218.x
Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121:2126-32. DOI: https://doi.org/10.1172/JCI58109
Schwabkey ZI, Jenq RR. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. Annu Rev Med. 2020; 71:137-48. DOI: https://doi.org/10.1146/annurev-med-052918-122440
Yaghoubi A, Khazaei M, Avan A, et al. The bacterial instrument as a promising therapy for colon cancer. Int J Colorectal Dis. 2020; 35:595-606. DOI: https://doi.org/10.1007/s00384-020-03535-9
Sekirov I, Russell SL, Antunes LCM, et al. Gut Microbiota in Health and Disease. Physiol Rev. 2010; 90:859-904. DOI: https://doi.org/10.1152/physrev.00045.2009
Yang B, Wang Y, Qian P-Y. Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis. BMC Bioinformatics. 1016; 17:135. DOI: https://doi.org/10.1186/s12859-016-0992-y
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394-424. DOI: https://doi.org/10.3322/caac.21492
Wu S, Rhee K-J, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009; 15:1016-22. DOI: https://doi.org/10.1038/nm.2015
Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005; 5:749-59. DOI: https://doi.org/10.1038/nri1703
Ocansey DKW, Wang L, Wang J, et al. Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clin Transl Med. 2019; 8:31. DOI: https://doi.org/10.1186/s40169-019-0251-8
Arthur JC, Pérez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012; 338:120-3. DOI: https://doi.org/10.1126/science.1224820
Loke MF, Chua EG, Gan HM, et al. Metabolomics and 16S rRNA sequencing of human colorectal cancers and adjacent mucosa. PLoS One. 2018;13. DOI: https://doi.org/10.1371/journal.pone.0208584
Dai Z, Coker OO, Nakatsu G, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018; 6:70. DOI: https://doi.org/10.1186/s40168-018-0451-2
Escobar JS, Klotz B, Valdés BE, et al. The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiol. 2014; 14:311. DOI: https://doi.org/10.1186/s12866-014-0311-6
Younossi ZM. Non-alcoholic fatty liver disease -A global public health perspective. J Hepatol. 2019; 70:531-44. DOI: https://doi.org/10.1016/j.jhep.2018.10.033
Sumida Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014; 20:475. DOI: https://doi.org/10.3748/wjg.v20.i2.475
Sharpton SR, Yong GJM, Terrault NA, et al. Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2019; 3:29-43. DOI: https://doi.org/10.1002/hep4.1284
Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology. 2013; 57:601-9. DOI: https://doi.org/10.1002/hep.26093
Aragonès G, González-García S, Aguilar C, et al. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease. Biomed Res Int. 2019; 2019:8507583 DOI: https://doi.org/10.1155/2019/8507583
Wong VW-S, Adams LA, de Lédinghen V, et al. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat Rev Gastroenterol Hepatol. 2018; 15:461-78. DOI: https://doi.org/10.1038/s41575-018-0014-9
Pirola CJ, Sookoian S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J Gastroenterol. 2018; 24:1601-15. DOI: https://doi.org/10.3748/wjg.v24.i15.1601
Brooks AW, Priya S, Blekhman R, et al. Gut microbiota diversity across ethnicities in the United States. PLOS Biol. 2018; 4:16-20. DOI: https://doi.org/10.1371/journal.pbio.2006842
Pinto Marques Souza de Oliveira C, Pinchemel Cotrim H, Arrese M. Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives. Clin Liver Dis (Hoboken). 2019; 13(2):39–42. DOI: https://doi.org/10.1002/cld.759
Han L, Zhao K, Li Y, et al. A gut microbiota score predicting acute graft‐versus‐host disease following myeloablative allogeneic hematopoietic stem cell transplantation. Am J Transplant. 2019; 4:56-9. DOI: https://doi.org/10.1111/ajt.15654
Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020; 382:822-34. DOI: https://doi.org/10.1056/NEJMoa1900623